Valuation: ABL Texcell Diagnostics

Market Cap 3.92Cr 4.5Cr 3.7Cr 3.36Cr 6.3Cr 431.46Cr 6.33Cr 44Cr 17Cr 219.36Cr 17Cr 17Cr 705.82Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.01Cr 4.6Cr 3.79Cr 3.44Cr 6.45Cr 441.72Cr 6.48Cr 45Cr 18Cr 224.58Cr 17Cr 17Cr 722.61Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
6.2%
Yield 2024
2.03%
Yield 2025 3.67%
1 day-5.43%
1 week-3.17%
1 month+3.39%
3 months-7.58%
6 months-27.38%
Current year-18.67%
1 week 2.42
Extreme 2.42
2.68
1 month 2.2
Extreme 2.2
2.78
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
28/07/26
Advanced Biological Laboratories SA
SellCompany -60,000 0.3723%
20/07/26
Advanced Biological Laboratories SA
SellCompany -65,616 0.4072%
06/07/26
Advanced Biological Laboratories SA
SellCompany -62,308 0.3867%
Change 5-day change 1-year change 3-year change Capi.($)
-5.43%-3.17%-44.55%-74.85% 4.5Cr
+0.37%+0.65%-24.57%+1.93% 18TCr
-0.69%+1.29%-3.10%+11.50% 12TCr
-0.20%-3.98%+6.47%+71.79% 5.89TCr
-0.24%+1.74%-3.26%-31.97% 4.93TCr
-0.22%-0.37%+10.27%+40.45% 4.82TCr
+1.61%+7.61%+32.47%-5.11% 3.37TCr
-1.49%-2.74% - - 2.78TCr
-1.17%+4.64%+42.17%-7.72% 2.55TCr
+1.02%+5.99%+6.51%-15.81% 2.21TCr
Average -0.64%+1.35%+2.49%-1.09% 5.61TCr
Weighted average by Cap. -0.08%+1.03%-3.19%+10.46%

Financials

2024 2025
Net sales 5.87 6.73 5.54 5.03 9.43 645.87 9.47 66.39 25.62 328.37 25.29 24.72 1.06T 7.97 9.13 7.52 6.83 12.8 876.54 12.85 90.1 34.77 445.65 34.32 33.55 1.43T
Net income 3L 3L 3L 2L 5L 3.14Cr 5L 32.25L 12.45L 1.6Cr 12.28L 12.01L 5.13Cr 10L 11.32L 9L 8L 15.85L 11Cr 15.92L 1.12Cr 43.07L 5.52Cr 42.51L 41.56L 18Cr
Net Debt 20.24L 23.21L 19.11L 17.35L 32.51L 22Cr 32.65L 2.29Cr 88.33L 11Cr 87.18L 85.25L 36Cr 9L 10.7L 9L 8L 14.98L 10Cr 15.05L 1.05Cr 40.71L 5.22Cr 40.18L 39.29L 17Cr
Logo ABL Texcell Diagnostics
ABL Texcell Diagnostics (formerly ABL Diagnostics) specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
18/26/18 €2.440 -5.43% 5,295
17/26/17 €2.580 +1.57% 2,231
16/26/16 €2.540 0.00% 4,545
15/26/15 €2.540 +4.96% 6,083
14/26/14 €2.420 -3.97% 6,018

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!